Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jul;144(1):306-309.e2.
doi: 10.1016/j.jaci.2019.02.020. Epub 2019 Mar 1.

T-cell mitochondrial dysfunction and lymphopenia in DOCK2-deficient patients

Affiliations
Case Reports

T-cell mitochondrial dysfunction and lymphopenia in DOCK2-deficient patients

Mohammed F Alosaimi et al. J Allergy Clin Immunol. 2019 Jul.

Abstract

This study delineates the mitochondrial defects in DOCK2-deficient T cells contributing to the T cell lymphopenia characteristic of this primary immunodeficiency.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no conflicts of interest.

Figures

Figure 1. A.
Figure 1. A.
DOCK2 schematic. B. PCR products from a control (C) and P1. C. Sanger sequencing around the mutation in P2 and a control. D. Immunoblot of DOCK2 in PBMCs from a control and patients. E. Mean fluorescence intensity (MFI) of dihydroethidium (DHE) in CD4+ and CD8+ T cells from four controls and patients. F. Extracellular flux analysis of the oxygen consumption rate (OCR) in resting T cells from two controls and patients. G. Numbers of live CD3+ T cells from four controls and patients after 24 hours of anti-CD3+anti-CD28 stimulation. H. MFI of DIOC6, which reflects mitochondrial membrane potential, in CD4+ T cells from four controls and P1 before and after activation. I. MFI of Mitotracker Green (MTG), which reflects mitochondrial mass, in CD4+ T cells from four controls and P1 before and after activation. J, K. MFI of DIOC6 (J) and MTG (K) in CD8+ T cells from four controls and P1 before and after activation. L. Proposed mechanism of mitochondrial dysfunction in DOCK2-deficient T cells. Data for panels E, G – K were pooled from four independent experiments. ns, not significant; *p<0.05; **p<0.01, ***p<0.001; ****p<0.0001 using one-way ANOVA for multiple comparisons or Student’s t test for two groups.
Figure E1.
Figure E1.
MFI of dihydroethidium (DHE) (A), Mitotracker Green (B), and DIOC6 (C) in CD4+ T cells from controls and the chronically infected patient with and without anti-CD3+anti-CD28 stimulation. MFI of dihydroethidium (DHE) (D), Mitotracker Green (E), and DIOC6 (F) in CD8+ T cells from controls and the chronically infected patient with and without anti-CD3+anti-CD28 stimulation.
Figure E2.
Figure E2.
MFI of dihydroethidium (DHE) (A), DIOC6 (B), and Mitotracker Green (C) in EBV-transformed lymphoblastoid B cell line (BLCL) from controls and P1.

References

    1. Dobbs K, Domínguez Conde C, Zhang S-Y, Parolini S, Audry M, Chou J, et al. Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections. N Engl J Med 2015;372:2409–22. - PMC - PubMed
    1. Nishihara H, Maeda M, Tsuda M, Makino Y, Sawa H, Nagashima K, et al. DOCK2 mediates T cell receptor-induced activation of Rac2 and IL-2 transcription. Biochem Biophys Res Commun 2002;296:716–20. - PubMed
    1. Alizadeh Z, Mazinani M, Shakerian L, Nabavi M, Fazlollahi MR. DOCK2 Deficiency in a Patient with Hyper IgM Phenotype. J Clin Immunol 2018;38:10–2. - PubMed
    1. Rissone A, Weinacht KG, la Marca G, Bishop K, Giocaliere E, Jagadeesh J, et al. Reticular dysgenesis-associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress. J Exp Med 2015;212:1185–202. - PMC - PubMed
    1. Tiede I, Fritz G, Strand S, Poppe D, Dvorsky R, Strand D, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 2003;111:1133–45. - PMC - PubMed

MeSH terms

Substances